TerrAscend Corp (TSNDF)

[jimmy lipper]

Any guess in quarterly sales? Think it will surprise. Been steady green.

[JohnCM]

I like both. Price action Terrascend better. Also, I am sticking with U.S.A.

[jimmy lipper]

Is that enough to leap frog aphria?

[JohnCM]

Aug 20, 2020

Based on the ongoing strength of the Company's operations, TerrAscend anticipates full year net sales of at least $192 million driven by second half 2020 net sales growth of at least 34% versus the first half of 2020 and 109% year over year. Adjusted EBITDA for the year is expected to be at least $45 million.

[jimmy lipper]

Will earnings be significant?

[splinter68]

Eff it, I’ll quote myself. Happy for those that got on for the ride.

[KarmaKing]

Barry White, Wine and Bowlage, your girl in front of a fire. Just sit back and relax$$ Watch this shizznizzle grow!

[CannaZoid]

Quietly, this is my best performer...

[jimmy lipper]

Over $7. Climb on board

[CannaZoid]

52 Week High!

[JohnCM]

Looking good!!

[CannaZoid]

https://finance.yahoo.com/news/terrascend-preannounces-strong-third-quarter-120000890.html

[JohnCM]

Motley Fool

The 3 Most Exciting Pot Stocks You're Overlooking

These cannabis stocks aren't getting a lot of attention yet, but they soon will be.

By Sean Williams
Sep 9, 2020

You might not know it by looking at the poor performance of most cannabis stocks over the past 17 months, but marijuana is projected to be one of the fastest-growing industries this decade. With tens of billions of dollars in North American pot sales conducted in the black market each year, Canada's legalization of adult-use weed in Oct. 2018 and a steady stream of state-level legalizations in the U.S. has rolled out the green carpet for illicit users to become legal-channel consumers.

This exceptional growth potential is what's encouraged investors to pile into the most prominent cannabis stocks. I'm talking about Canopy Growth and Aurora Cannabis in Canada and U.S. multistate operators (MSOs) like Curaleaf, Green Thumb Industries, Cresco Labs, and Trulieve Cannabis.

But the thing is, most marijuana stock investors know or follow these companies. If you want truly exciting pot stocks that aren't yet on many investors' radars, then take a gander at these three cannabis companies.

TerrAscend

If you're torn between investing in the U.S. or Canadian market, TerrAscend (OTC:TRSSF) is the pot stock you'll want to pay close attention to. That's because it has a presence in both Canada's retail and medical weed market and acts as an MSO in three U.S. states (Pennsylvania, New Jersey, and California).

Within the U.S., TerrAscend's focus is on limited license markets, like Pennsylvania and New Jersey, as well as high-dollar markets, such as California. The Golden State is the largest pot market in the world by annual sales. TerrAscend currently operates four stores but has a license for a fifth, all of which are located in the high-income San Francisco Bay area. TerrAscend's products can be found in more than 90 dispensaries throughout California.

Including New Jersey and Pennsylvania, TerrAscend has seven open dispensaries in the U.S. but outlined plans in its most recent investor presentation to open two dispensaries each quarter, through the first quarter of 2021.

TerrAscend's success also derives from its role in selling high-margin derivatives. The company's Funky Farms and Original Hemp brands can be found in more than 10,000 stores throughout the U.S. and include a variety of tinctures, edibles, vapes, and gel caps. Since derivative products boast higher price points, they'll play a key role in the company's push toward profitability.

Speaking of that push, TerrAscend has delivered two-consecutive quarters of positive earnings before interest, taxes, depreciation, and amortization (EBITDA), with the company actually generating about 4 million Canadian dollars in operating income, before taking fair-value adjustments and other income/expenses into account, in the second quarter. In other words, TerrAscend is creeping up on recurring profitability, which means investors should be paying close attention.

Jushi Holdings

Another MSO that's flying under the radar of most pot stock investors is Florida-headquartered Jushi Holdings (OTC:JUSHF). With a $228 million market cap, Jushi is bordering on microcap territory and is therefore going to be overlooked by lots of investors. That could be a mistake.

Similar to TerrAscend, Jushi is a big fan of targeting limited-license markets. By focusing on states that allow for limited competition (i.e., competitive advantages), MSOs like Jushi will be able to keep their marketing and build-out costs reasonably low while ensuring a steady stream of growth and demand. In particular, Jushi's focus is on Pennsylvania, Illinois, and Virginia.

Following the company's acquisition of an 80% stake in Agape Total Health Care in June, Jushi can now open as many as 15 retail locations in Pennsylvania. That's great news, considering it reported organic same-store sales growth of 50% in the Keystone State from the sequential first quarter.

Organic same-store sales grew an even more robust 330% in the company's two open Illinois locations from the sequential quarter. By 2024, Illinois is expected to be generating north of $1 billion in annual weed sales per year. Jushi has the ability to double its retail locations in the Land of Lincoln to four.

As of July, the company had an annual run rate of $89 million in sales but has forecast $200 million to $250 million in full-year revenue for 2021. Part of this will come from new stores being opened, and some will be the result of the company's aforementioned rapid organic growth. More important, Jushi expects to be generating positive adjusted EBITDA by the fourth quarter of 2020.

As one added note, Jushi is well-capitalized, and its executives have played a role in securing the company's financial foundation by putting up some of their own money in previous rounds of financing. Generally speaking, companies with executives who have serious skin in the game are businesses you'll want to follow.

Planet 13 Holdings

A final exciting overlooked pot stock that you're going to want to get on your radar is U.S. MSO Planet 13 Holdings (OTC:PLNH.F).

Planet 13 is definitely a bit different than the highly followed and even under-the-radar MSOs I've listed above. Instead of targeting as many states as possible, Planet 13 is all about the "wow" factor. That's because its only open dispensary right now is the 112,000-square-foot SuperStore located west of the Las Vegas Strip.

For some context here, the average Walmart is only 105,000 square feet. Inside the company's SuperStore, you'll find a consumer-facing processing center, an events stage, a restaurant, and plenty of square footage devoted to the broadest selection of dried flower, derivatives, and paraphernalia that you'll ever see.

I actually visited the SuperStore in April 2019, well before any of its ancillary ventures (the processing center and restaurant) were complete. What really stood out was both the store layout and the focus on convenience. Planet 13 offers personal budtenders to aid consumers with their purchases, but also has self-pay kiosks located in high-traffic areas (e.g., the dried cannabis display case) to expedite sales for return customers. In terms of layout, the highest-margin derivatives are conveniently placed near the front of the store and by the registers.

While there's no question that the pandemic clobbered Planet 13 and its tourist-heavy business model for a few months, the company's focus on deliveries to locals has added a new growth element that didn't exist before.

Planet 13 is also planning to open its second megadispensary in Santa Ana, Calif., with 40,000 square feet, later this year. The company is hoping to replicate its success in Las Vegas and become the must-see cannabis destination in the most lucrative weed market in the world. It's absolutely a pot stock you'll want to monitor very closely.

[JohnCM]

Seeking Alpha

TerrAscend: A Growing Cannabis Stock That Actually Makes Money
Oct. 20, 2020 5:34 PM ET
About: TerrAscend Corp. (TRSSF)

While most cannabis stocks have been reeling from the oversupply and overbuild issues, TerrAscend has quietly built itself into a profitable company.

[JohnCM]

$5.00 to $5.50 buy looks good.

[JohnCM]

TerrAscend Reports Strong Second Quarter 2020 Net Sales of $47.2 Million and Adjusted EBITDA of $11.4 Million

[JohnCM]

Impressive!!

Outstanding Shares
77,004,321
10/23/2020

[jimmy lipper]

Massive gap in the bid/ask this morning? Merger?

[jimmy lipper]

Do they have a significant presence in NJ, PA, NY, CT?

[KarmaKing]

Great Freaking Company!!

[KarmaKing]

Greatly and Yes!

[jimmy lipper]

How will nov 3rd NJ vote effect this stock? Do they have a strong northeast presence?

[KarmaKing]

THAT"S A BINGO!!! Is that how you say it.... Inglorious Basterds

[CannaZoid]

They seem to be growing and executing well! The 5th great MSO? Hmmmm

https://www.terrascend.com/terrascend-reports-strong-second-quarter-2020-net-sales-of-47-2-million-and-adjusted-ebitda-of-11-4-million/

[CannaZoid]

Loving It!

[KarmaKing]

There's somethin happen here...What it is ain't exactly clear.... What's going on with this stuff?

[KarmaKing]

Been watching for a while wish I got in June at 1.9 Lol Got in at 3.77 up 5%

[splinter68]

What took you so long? Glad you are here regardless.

[KarmaKing]

Hello!!! Hello!! Hello

[splinter68]

This board is much quieter than it should be. That will change.

[CannaZoid]

Earnings reported. Canopy Support. Anyone listen to the conference call? Anything good to say?

[CannaZoid]

Yeah. These guys have a support safety net with Canopy. Don’t know why it’s been under pressure since the news. I’d say they got themselves set up for the long haul...

[geodcan]

https://stockhouse.com/news/newswire/2020/03/11/canopy-growth-enters-into-debt-financing-arrangement-with-terrascend

Same kind of a deal that Canopy Growth has inked with Acreage Holdings for sometime off in the future or when the States legalizes marijuana at the Federal level. Also $80 million loan to Terrascend. It seems that these guys are planning for the future in a progressive manner which is better than doing damage control in a reactive manner. I like progressive future see'ers and a long term plan. Most marijuana companies just got the killing blow and are off to the slaughterhouse, but not these guys. Executing business plans to reach goals as opposed to flash in the pan players. glta and dyodd

[KarmaKing]

Not alot of noise, I really like this company!

[CannaZoid]

TerrAscend! My best stock of the day! Let’s be stoked people!

[Golden Cross]

News - TerrAscend Canada Triples Licensed Cultivation and Processing Capacity
Canada NewsWire

TORONTO, Oct. 7, 2019

--- Health Canada's approval of additional licensed space at Mississauga, Ontario facility provides significant scale in production and processing.

--- Additional licensed cultivation capacity earmarked to further serve the EU and other international markets.

--- Newly licensed processing operations readies TerrAscend for Canadian Cannabis 2.0 implementation.

TORONTO, Oct. 7, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that it has received approval from Health Canada for significant expansion at its facility in Mississauga, Ontario. This approval increases licensed space at the Mississauga facility nearly three-fold from 17,800 sq. ft. to 51,800 sq. ft., and includes additional cultivation capacity, a commercial kitchen, formulation rooms and increased primary and secondary packaging capacity to allow for new product formats and extracts for the Canadian Cannabis 2.0 market.

www.TerrAscend.com (CNW Group/TerrAscend)

"Achieving this approval milestone is a crucial step in our plan to cultivate premium grade cannabis at scale for distribution to the EU and other international markets," said Michael Nashat, CEO of TerrAscend. "In addition, our newly licensed processing operations pave the way for TerrAscend to meet the significant increased consumer demand expected upon the launch of Cannabis 2.0. Over the coming months, we plan on introducing the Canadian market to the proven brands and formulations from our US operations, as well as new proprietary dosage forms developed in our EU GMP certified Ontario-based facility."

First licensed for cultivation in July 2017, TerrAscend's 67,300 sq. ft. GMP certified indoor cannabis facility located in Mississauga, Ontario, is focused on serving the Canadian medical and adult-use markets, conducting research & development for plant sciences and formulations, and serving as a platform for export of cannabis products to Europe and other international jurisdictions.

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend
TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. TerrAscend is the first and only cannabis company with sales in the US, Canada, and Europe as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario. TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ilera Healthcare, Pennsylvania's premier medical marijuana cultivator, processor and dispenser; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; Solace RX Inc., a proposed Drug Preparation Premises (DPP) focused on the development of novel formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. Additionally, TerrAscend has been chosen by the state of New Jersey to be one of six permit applicants for a vertically integrated medical cannabis operation. For more information, visit www.terrascend.com.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance.

[Golden Cross]

TerrAscend to Present at Upcoming Conferences
www.TerrAscend.com (CNW Group/TerrAscend)
NEWS PROVIDED BY

TerrAscend
Sep 27, 2019, 07:30 ET

TORONTO, Sept. 27, 2019 /PRNewswire/ - TerrAscend Corp. (CSE: TER;OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that its leadership will be participating in the following upcoming conferences.

Canopy Rivers Cannabis Symposium, Toronto, October 2, 2019: Jason Wild, Chairman of TerrAscend, will sit for a fireside chat with Narbe Alexandrian, Chief Executive Officer of Canopy Rivers, entitled "TerrAscend's Expansion Strategy - Path to Becoming a Top Five MSO". The fireside chat will take place on October 2, 2019, at 1:30p.m. ET, at the TIFF Bell Lightbox theatre. This half-day symposium will include a series of discussions on topics ranging from cannabis brand strategy to the biosynthesis of cannabinoids. Investors can watch the live stream of the symposium on YouTube at http://bit.ly/CanopyRiversCannabisSymposium.

Canaccord Genuity 2nd Annual U.S. Cannabis Symposium, Toronto, October 3, 2019: Heather Molloy, EVP Business Development of TerrAscend, will present at the Canaccord Genuity 2nd Annual U.S. Cannabis Symposium. The presentation will take place on October 3, 2019, at 3:10 p.m. ET, at the Sheraton Centre Toronto Hotel. In addition to the presentation, Michael Nashat, Chief Executive Officer of TerrAscend, Jason Wild, and other members of the TerrAscend leadership team will participate in investor meetings throughout the day. This one-day symposium will feature company presentations and meetings with senior management teams across the U.S. cannabis industry supply chain, including multi-state operators, technology providers, brand owners, hemp producers, oil extractors and ancillary products businesses. Investors interested in attending the conference or arranging a meeting with TerrAscend leadership should contact their Canaccord representative.

About TerrAscend
TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. TerrAscend is the first and only cannabis company with sales in the US, Canada, and Europe as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario. TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ilera Healthcare, Pennsylvania's premier medical marijuana cultivator, processor and dispenser; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; Solace RX Inc., a proposed Drug Preparation Premises (DPP) focused on the development of novel formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. Additionally, TerrAscend has been chosen by the state of New Jersey to be one of six permit applicants for a vertically integrated medical cannabis operation. For more information, visit www.terrascend.com.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. Due to any investments made by TerrAscend in operations in the United States, enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance.

SOURCE TerrAscend

[wsstocks]

TerrAscend Reports Record Q1 2019 Revenue

View here

[RTupp23]

TER 1st Company with US, CDN & EU Sales + Buy/Sell Signal & Chart

View here

[RTupp23]

TerrAscend Q4 Financials + Buy/Sell TA Signal & Chart

View here

[RTupp23]

TerrAscend Issues Full Year 2019 Revenue Guidance

+ Technical Chart and Technical Analysis Signal (Buy, Strong Buy, Neutral, Sell, Strong Sell)

Read here

[DD8]

San Francisco cannabis retailer acquired by Canada’s TerrAscend for $118M:
https://mjbizdaily.com/san-francisco-cannabis-retailer-acquired-canada-terrascend/

[nowwhat2]

A fairly sound (graphic) review of Shennanigans :








10 days later....(6 trading days) - Ruler-lines Target reiterated.









BOOM !....











2 weeks later :











About 6 days later : (what's up with that Volume ?)












Just hours before....The Beginning :











NEXT DAY :


LoL








Day after that :











3 days later :











And 5 days later :







So what am I striving to communicate here ?......Well c'mon !




Because it's OBVIOUS ain't it ?.....Any ROOKIE can call this crap !





It's all frickin' chart-based manipulation.....






It's nothing at-all fancy.







People'll say "Oh, it is this and it's that...."







But it's really just simple old fashioned T.A.

[nowwhat2]

Today (next day) (thus far) it has traded as high as 7.78 (up another 8 %)

Yesterday :




4 or 5 days earlier :




Thing's suddenly 33 % above that line

[JohnCM]

I am just saying that Terrascend has been late to follow the uptick. I would love for this stock to follow the support line. Keep it going. Terrascend has been my worst performer, although I like the company.

[nowwhat2]

So - one can attribute this move to quote : "the uptick in MJ" but..... NOT to the/a/my basic Ruler-Line (you're sayin') ?



Nah....I'll stick with MY reasonings for the move man, thanks.







3 days before the rise began :







Hmmmm - Ah, ok - Actually = Closed at 7.12 - Ok so.....It's up 25 % off The Line




And I imagine yer right - That it's ON NO NEWS . . . .




So, it'd be a 100 % TA - Ruler Line Move







Or, as you like to put it : It's an......Attributable to "the uptick in MJ" Move






Not what I'd call it - It's a Ruler Line Move !

[JohnCM]

Finally the uptick in MJ had an influence on TRSSF.

This last MJ trend has been gentle and not hyperbolic.

[nowwhat2]

Just need nice ruler-lines :

News (obviously) not required.







3 trading days ago :

[JohnCM]

Big move. No news?

[nowwhat2]

Canopys' partner - TerrAscend ;


Friday / Monday / Tuesday (today) :


Friday :







Next day : Monday (MLK Day - US mkts closed) Up 5 % - (was suddenly 10 % up off The Line)





Next day (Tuesday) Up today 7.9 % thus far






Because that is what ruler-lines just simply DO !.....


I know absolutely NOTHING about the company (why bother DD-ing when one doesn't NEED to) ?


Why bog oneself down in that dumb "murky" world ?



Stock chart analysis is MY DD !